Microbial production of bioactives: From fermented functional foods to probiotic mechanisms

Australian Journal of Dairy Technology

Volumn 64, Issue 1, 2009, Pages 41-49

  Mills, Susan ^a,b   Stanton, Catherine ^a,b   Ross, R Paul ^a,b  

^a TEAGASC FOOD RESEARCH CENTRE   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS);

EID: 63749084133     PISSN: 00049433     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (154)

1. Abdou, A.M., Higashiguchi, S., Horie, K., Kim, M., Hatta, H. and Yokogoshi, H. (2006), Relaxation and immunity enhancement of γ-aminobutyric acid (GABA) administration in humans BioFactors 26, 201-208.
2. Adamson, N.J. and Reynolds, E.C. (1995), Characterisation of tryptic casein phosphopeptides prepared under industrially relevant conditions. Biotechnol. Bioeng. 45, 196-204.
3. Adamson, N.J. and Reynolds, E.C. (1996), Characterisation of casein phosphopeptides prepared using alcalase: Determination of enzyme specificity. Enzyme Microbiol. Technol. 19, 202-207.
4. Aimutis, W.R. (2004), Bioactive properties of milk proteins with particular focus on anticariogenesis. J. Nutr. 134, 989S-995S.
5. Akuzawa, R. and Fox, P.F. (2004), Acid phosphatase in cheese. Anim. Sci. J. 75, 385-391.
6. Alonso, L., Cuesta, E.P. and Gilliland, S.E. (2003), Production of free conjugated linoleic acid by Lactobacillus acidophilus and Lactobacillus casei of human intestinal origin. J. Dairy Sci. 86, 1941-1946.
7. Andrieux, A., Hudry-Clergeon, G., Ryckewaert, J.J., Chapel, A., Ginsberg, M.H., Plow, E.F. and Marguerie, G. (1989), Amino acid sequences in fibrinogen mediating its interaction with its platelet receptor, GPIIbIIIa. J. Biol. Chem. 264, 9258-9265.
8. Aneja, R.P. and Murthi, T.N. (1990), Conjugated linoleic acid contents of Indian curds and ghee. Indian J. Dairy Sci. 43, 231-238.
9. Aquilar, E., Tena-Sempere, M. and Pinilla, L. (2005), Role of excitatory amino acids in the control of growth hormone secretion. Endocrine Reviews 28, 295-302.
10. Ayebo, A.D., Shahani, K.M., Dam, R. and Friend, B.A. (1982), Ion exchange separation of the antitumor component(s) of yogurt dialyzate. J. Dairy Sci. 65, 2388-2390.
11. Barrett, E., Ross, R.P., Fitzgerald, G.F. and Stanton, C. (2007), Rapid screening method for analyzing the conjugated linoleic acid production capabilities of bacterial cultures. Appl Environ Microbiol 73, 2333-2337.
12. Barrett, E., Stanton, C., Fitzgerald, G.F. and Ross, R.P. (2003), Biotechnology of food cultures for the nutritional enhancement of milk and dairy products. In Handbook of Functional Dairy Products. (Eds C. Shortt and J. O' Brien). CRC Press, pp 255-274.
13. Beaulieu, J., Dubuc, R., Beaudet, N., Dupont, C. and Lemieux, P. (2007), Immunomodulation by a malleable matrix composed of fermented whey proteins and lactic acid bacteria. J. Med. Food 10, 67-72.
14. Belury, M.A. (2002), Inhibition of carcinogenesis by conjugated linoleic acid: potential mechanisms of action. J. Nutr. 132, 2995-2998.
15. Bhattacharya, A., Banu, J., Rahman, M., Causey, J. and Fernandes, G. (2006), Biological effects of conjugated linoleic acids in health and disease. J. Nutr. Biochem. 17 789-810.
16. Biffi, A., Coradini, D., Larsen, R., Riva, L. and G., D.F. (1997), Antiproliferative effect of fermented milk on the growth of a human breast cancer cell line. Nutr. Cancer 28, 93-99.
17. Brownbill, R.A., Petrosian, M. and Ilish, J.Z. (2005), Association between dietary conjugated linoleic acid and bone mineral density in postmenopausal women. J. Am. Nutr. 24, 177-181.
18. Caen, J., Jolies, P., Bal dit Sollier, C., Fiat, A.-M. and al., e. (1992), Anti-thrombotic activity of milk protein peptide sequences. Cahiers de Nutrition et de Dietique 27, 33-35.
19. Castanie-Comet, M.-P., Penfound, T.A., Smith, D., Elliott, J.F. and Foster, J.W. (1999), Control of acid resistance in Escherichia coli. J. Bacterial. 181, 3525-3535.
20. Cavagnini, E, Benetti, G., Invito, C., Ramella, G., Pinto, M., Lazza, M., Dubini, A., Marelli, A. and Muller, E.E. (1980a), Effect of gamma-aminobutyric acid on growth hormone and prolactin secretion in man: influence of pimozide and domperidone. J. Clin. Endocrinol. Metab. 51, 789-792.
21. Cavagnini, E, Invitti, C., Pinto, M., Maraschini, C., Di Landro, A., Dubini, A. and Marelli, A. (1980b), Effect of acute and repeated administration of gamma aminobutyric acid (GABA) on growth hormone and prolactin secretion in man. Acta. Endocrinol. 93, 149-154.
22. Chabance, B., Jolies, P., Izquierdo, C., Mazoyer, E., Francoual, C., Drouet, L. and Fiat, A.M. (1995), Characterisation of an antithrombotic peptide from kappa-casein in newborn plasma after milk ingestion. Br. J. Nutr. 73 583-590.
23. Chin, S.F., Storkson, J.M., Albright, K.J., Cook, M.E. and Panza, M.W. (1994), Conjugated linoleic acid is a growth factor for rats as shown by enhanced weight gain and improved feed efficiency. J. Nutr. 124, 2344-2349.
24. Cho, Y.R., Chang, J. Y. and Chang, H.C. (2007), Production of gamma-aminobutyric acid (GABA) by Lactobacillus buchneri isolated from kimchi and its neuroprotective effect on neuronal cells. J. Microbiol. Biotechnol. 17, 104-109.
25. Clare, D.A., Catignani, G.L. and Swaisgood, H.E. (2003), Biodefense properties of milk: the role of antimicrobial proteins and peptides. Curr. Pharm. Des. 9, 1239-1255.
26. Clare, D.A. and Swaisgood, H.E. (2000), Bioactive milk peptides: a prospectus. J. Dairy Sci. 83, 1187-1195.
27. Coakley, M., Johnson, M.C., McGrath, E., Rahman, S., Ross, R.P., Fitzgerald, G.F., Devery, R. and Stanton, C. (2006), Intestinal bifidobacteria that produce trans-9, trans-11 CLA: a fatty acid with anti-proliferative activity against human colon SW480 and HT-29 cancer cells. Nutr. Cancer 56, 95-102.
28. Coakley, M., Ross, R.P., Nordgren, M., Fitzgerald, G., Devery, R. and Stanton, C. (2003), Conjugated linoleic acid biosynthesis by human-derived Bifidobacterium species. J. Appl. Microbiol. 94, 138-145.
29. Cotter, P.D., Ganan, C.G. and Hill, C. (2001a), A glutamate decarboxylase system protects Listeria monocytogenes in gastric fluid. Mol. Microbiol. 40, 465-475.
30. Cotter, P.D, O'Reilly, K. and Hill, C. (2001b), Role of the glutamate decarboxylase acid resistance system in the survival of Listeria monocytogenes LO28 in low pH foods. J. Food Prot. 64, 1362-1368.
31. de Vrese, M. and Marteau, P.R. (2007), Probiotics and prebiotics: effects on diarrhea. J. Nutr. 137, 803S-811S.
32. Dionysius, D.A., Marschke, R.J., Wood, A.J., Milne, J., Beattie, T.R., Jiang, H., Treloar, T., Alewood, P.F. and Grieve, P.A. (2000), Identification of physiologically functional peptides in dairy products. Aust. J. Dairy Technol. 55, 103.
33. Drouet, L., Bal dit Sollier, C., Cisse, M., Pignaud, G., Mazoyer, E., Fiat, A.M., Jolies, P. and J.P., C. (1990), The antithrombotic effect of KRDS, a lactotransferrin peptide, compared with RGDS. Nouv. Rev. Fr. Hematol. 32, 59-62.
34. Erba, D., Ciappellano, S. and Testolin, G. (2002), Effect of the ratio of casein phosphopeptides to calcium (w/w) on passive calcium transport in the distal small intestine of rats. Nutrition 18, 743-746.
35. Ferraretto, A., Signorile, A., Gravaghi, C., Fiorilli, A. and Tettamanti, G. (2001), Casein phosphopeptides influence calcium uptake by cultured human intestinal HT-29 tumor cells. J. Nutr. 131, 1655-1661.
36. Foltz, M., Meynen, E.E., Bianco, V., van Platerink, C., Koning, T.M. and Kloek, J. (2007), Angiotensin converting enzyme inhibitory peptides from a lactotripeptide-enriched milk beverage are absorbed intact into the circulation. J. Nutr. 137, 953-958.
37. Fox, P.F. (1993), Cheese; Chemistry, Physics and Microbiology, Chapman and Hall: London.
38. Francis, G.A., Scollard, J., Meally, A., Bolton, D.J., Ganan, C.G., Cotter, P.D., Hill, C. and O'Beirne, D. (2007), The glutamate decarboxylase acid resistance mechanism affects survival of Listeria monocytogenes LO28 in modified atmosphere-packaged foods. J. Appl. Microbiol. 103, 2316-2324.
39. Fuglsang, A., Nilsson, D. and Nyborg, N.C. (2002), Cardiovascular effects of fermented milk containing angiotensin-converting enzyme inhibitors evaluated in permanently catheterized, spontaneously hypertensive rats Appl. Environ. Microbiol. 68, 3566-3569.
40. Fuller, R. (1989), Probiotics in man and animals. J. Appl. Bacteriol. 66, 365-378.
41. Gillis, R.A., DiMicco, J.A., Williford, D.T., Hamilton, B. and Gale, K.N. (1980), Importance of CNS GABAergic mechanisms in the regulation of cardiovascular function Brain Res. Bull. 5 303S-315S.
42. Giuliani, S., Maggi, C., A. and Meli, A.D. (1986), Differences in cardiovascular responses to peripherally administered GABA as influenced by basal conditions and type of anaesthesia Br. J. Pharmac. 88, 659-670.
43. Gobbetti, M., Ferranti, P., Smacchi, E., Goffredi, F. and Addeo, F. (2000), Production of angiotensin-I-converting-enzyme-inhibitory peptides in fermented milks started by Lactobacillus delbrueckii subsp bulgaricus SS1 and Lactococcus lactis subsp. cremoris FT4. Appl. Environ. Microbiol. 66, 3898-3904.
44. Gobetti, M., Minervini, F. and Rizzello, C.G. (2004), Angiotensin I-converting-enzyme-inhibitory and antimicrobial bioactive peptides. Int. J. Dairy Technol. 57, 173-188.
45. Grenby, T.H., Andrews, A.T., Mistry, M., Williams, R.J.H. and Dentist, J. (2001), Dental caries-protective agents in milk products: Investigations in vitro. 29, 83-92.
46. Griinari, J.M. and Bauman, D.E. (1999), Biosynthesis of conjugated linoleic acid and its incorporation into meat and milk in ruminants. In Advances in Conjugated Linoleic Acid. (Eds M.P. Yurawecz, M.M. Mossoba, J.K.G. Kramer, M.W. Pariza and G.J. Nelson). AOCS Press: Champaign, IL. pp 180-200.
47. Ha, Y.L., Grimm, N.K. and Pariza, M.W. (1989), Newly recognized anticarcinogenic fatty acids: identification and quantification in nature and processed cheeses. J. Agric. Food Chem, 37, 75-81.
48. Hamel, U., Kielwein, G. and Teschemacher, H. (1985), b-Casomorphin immunoreactive materials in cows' milk incubated with various bacterial species. J. Dairy Res. 52, 139-148.
49. Hansen, E.B. (2002), Commercial bacterial starter cultures for fermented foods of the future. Int. J. Food Microbiol. 78, 119-131.
50. Hardy, G. (2000), Nutraceuticals and functional foods: introduction and meaning. Nutrition 16, 688-689.
51. Hata, Y., Yamamoto, M., Ohni, M., Nakajima, K., Nakamura, Y. and Takano, T. (1996), A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am. J. Clin. Nutr. 64, 767-771.
52. Hayakawa, K., Kimura, M., Kasaha, K., Matsumoto, K., Sansawa, H. and Yamori, Y. (2004), Effect of γ-aminobutyric acid-enriched dairy product on the blood pressure of spontaneously hypertensive and normotensive Wistar-Kyoto rats. Br. J. Nutr. 92, 411-417.
53. Hayes, M., Ross, R.P., Fitzgerald, G.F., Hill, C. and Stanton, C. (2006), Casein-derived antimicrobial peptides generated by Lactobacillus acidophilus DPC6026. Appl Environ Microbiol 72, 2260-2264.
54. Hayes, M., Ross, R.P., Fitzgerald, G.F. and Stanton, C. (2007a), Putting microbes to work: dairy fermentation, cell factories and bioactive peptides. Part I: overview. Biotechnol. J. 2, 426-434.
55. Hayes, M., Stanton, C., Fitzgerald, G.F. and Ross, R.P. (2007b), Putting microbes to work: dairy fermentation, cell factories and bioactive peptides. Part II: Bioactive peptide functions. Biotechnol. J. 2, 435-449.
56. Hayes, M., Stanton, C., Slattery, H., O' Sullivan, O., Hill, C., Fitzgerald, G.F. and Ross, R.P. (2007c), Casein fermentate of Lactobacillus animalis DPC6134 contains a range of novel propeptide angiotensin-converting enzyme inhibitors. Appl. Environ. Microbiol. 73, 4658-4667.
57. Hirayama, K. and Rafter, J. (2000), The role of probiotic bacteria in cancer prevention. Microbes Inject. 2, 681-686.
58. Hirota, T., Ohki, K., Kawagishi, R., Kajimoto, Y., Mizuno, S., Nakamura, Y. and Kitakaze, M. (2007), Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin-converting enzyme. Hypertens. Res. 30, 489-496.
59. Inoue, K., Shirai, T., Ochiai, H., Kasao, M., Hayakawa, K., Kimura, M. and Sansawa, H. (2003). Blood-pressure-lowering effect of a novel fermented milk containing γ-aminobutyric acid (GABA) in mild hypertensives Eur. J. Clin. Nutr. 57, 490-495.
60. Jaudszus, A., Foerster, M., Kroegel, C., Wolf, I. and Jahreis, G. (2005), Cis-9,trans-11-CLA exerts anti-inflammatory effects in human bronchial epithelial cells and eosinophils: comparison to frans-10,cis-12-CLA and to linoleic acid. Biochim. Biophys. Acta 1737, 111-118.
61. Jiang, J., Bjorck, L. and Fonden, R. (1998), Production of conjugated linoleic acid by dairy starter cultures. J. Appl. Microbiol. 85, 95-102.
62. Jolies, P. (1975), Structural aspects of the milk clotting process. Comparative features with the blood clotting process. Mol. Cell. Biochem. 7. 73-85.
63. Jolies, P. and Henschen, A. (1982), Comparison between the cloning of blood and milk. Trends Biochem. Sci. 7, 325-328.
64. Jolies, P., Levy-Toledano, S., Fiat, A.M., Soria, C., Gillessen, D., Thomaidis, A. Dunn, F. W. and Caen, J.P. (1986), Analogy between fibrinogen and casein. Effect of an undecapeptide isolated from kappa-casein on platelet function. Eur. J. Biochem. 158, 379-382.
65. Jolies, P., Loucheux-Lefebvre, M.H. and Henschen, A. (1978). Structural relatedness of κ-casein and fibrinogen γ-chain. J. Mol. Evol. 11, 271-277.
66. Joseph, J., Niggemann, B., Zaenker, K.S. and Entschladen, F. (2002), The neurotransmitter γ-aminobutyric acid is an inhibitory regulator for the migration of SW480 colon carcinoma cells Cancer Res. 62 6467-6469.
67. Juillard, V., Laan, H., Kunji, E.R., Jeronimus-Stratingh, C.M., Bruins, A.P. and Konings, W.N. (1995), The extracellular PI-type proteinase of Lactococcus hydrolyzes beta-casein into more than one hundred different oligopeptides. J. Bacteriol. 177, 3472-3478.
68. Kelley, N.S., Hubbard, N.E. and Erickson, K.L. (2007), Conjugated linoleic acid isomers and cancer. J. Nutr. 137, 2599-2607.
69. Kim, H.Y., Yokozawa, T., Nakagawa, T. and Sasaki, S. (2004), Protective effect of gamma-aminobutyric acid against glycerol-induced acute renal failure in rats Food Chem. Toxicol. 42 2009-2014.
70. Kishino, S., Ogawa, J., Omura, Y., Matsumura, K. and Shimizu, S. (2002), Conjugated linoleic acid production from linoleic acid by lactic acid bacteria. J. Am. Oil Chem. Soc. 79, 159-163.
71. Korhonen, H. and Pihlanto, A. (2003), Food-derived bioactive peptides-opportunities for designing future foods. Curr. Pharm. Des. 9, 1297-1308.
72. Kotilainen, L., Rajalahti, R., Ragasa, C. and Pehu, E. (2006), Health enhancing foods: Opportunities for strengthening the sector in developing countries. Agric. Rural Dev. Discussion Paper 30.
73. Lahov, E. and Regelson, W. (1996), Antibacterial and immunostimulating casein-derived substances from milk: Caseicidin, isracidin peptides. Food Chem. Toxicol. 34, 131-145.
74. LeBlanc, J., Fliss, I. and Matar, C., (2004), Induction of a humoral immune response following an Escherichia coli O157:H7 infection with an immunomodulatory peptidic fraction derived from Lactobacillus helveticus-fermented milk. Clin. Diagn. Lab. Immunol. 11, 1171-1181.
75. LeBlanc, J.G., Matar, C., Valdez, J.C., LeBlanc, J. and Perdigon, G. (2002). Immunomodulating effects of peptidic fractions issued from milk fermented with Lactobacillus helveticus. J. Dairy Sci. 85, 2733-2742.
76. Leroy, F. and De Vuyst, L. (2004), Lactic acid bacteria as functional starter cultures for the food fermentation industry. Trends Food Sci. Technol. 15, 67-78.
77. Lin, J., Lee, I.S., Frey, J., Slonczewski, J.L. and Foster, J.W. (1995), Comparative analysis of extreme acid survival in Salmonella typhimurium, Shigella flexineri and Escherichia coli. J. Bacteriol. 177, 4097-4104.
78. Lin, T.Y., Lin, C.W. and Lee, C.H. (1999), Conjugated linoleic acid concentration as affected by lactic cultures and added linoleic acid. Food Chem. 67, 1-5.
79. Lock, A.L. and Bauman, D.E. (2004), Modifying milk fat composition of dairy cows to enhance fatty acids beneficial to human health. Lipids 39, 1197-1206.
80. Losacco, M., Gallerani, R., Gobbetti, M., Minervini, F. and De Leo, F. (2007), Production of active angiotensin-I converting enzyme inhibitory peptides derived from bovine beta-casein by recombinant DNA technologies. Biotechnol. J. 2, 1425-1434.
81. Lund, M. and Ardo, Y. (2004), Purification and identification of water-soluble phosphopeptides from cheese using Fe(III) affinity chromatography and mass spectrometry. J. Agric. Food Chem. 52, 6616-6622.
82. Luo, S.J. and Wong, L.L. (2007), Oral care chewing gums and confections. In US Patent Number EP1176939
83. Macdonald, R.L. and Olsen, R.W. (1994), GABAA receptor channels. Annu. Rev. Neurosci. 17, 569-602.
84. Maeno, M., Yamamoto, N. and Takano, T. (1996), Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP190, J. Dairy Sci. 79, 1316-1321.
85. Matar, C. and Goulet, J. (1996), β-Casomorphin 4 milk fermented by a mutant of Lactobacillus helveticus. Int. Dairy J. 6, 383-397.
86. McCann, S.M. and Rettori, V. (1986), Gamma aminobutyric acid (GABA) controls anterior pituitary hormone secretion. Adv. Biochem. Psychopharmacol. 42 173-189.
87. McCann, S.M., Vijayan, E., Negro-Vilar, A. Mizunuma. H. and Mangat, H. (1984). Gamma aminobutyric acid (GABA), a modulator of anterior pituitary hormone secretion by hypothalamic and pituitary action. Psychoneitmenocrinology 9, 97-106.
88. Meisel, H. (1997), Biochemical properties of bioactive peptides derived from milk proteins: potential nutraceuticals for food and pharmaceutical applications. Lifestock Prod. Sci. 50, 125-138.
89. Meisel, H. and Bockelmann, W. (1999), Bioactive peptides encrypted in milk proteins: proteolytic activation and thropho-functional properties. Antonie Van Leeuwenhoek 76, 207-215.
90. Meisel, H. and Fitzgerald, R.J. (2000), Opioid peptides encrypted in intact milk protein sequences. Br. J. Nutr. 84, S27-S31.
91. Meisel, H. and Gunther, S. (1998), Food proteins as precursors of peptides modulating human cell activity (short communication). Nahrung 42, 175-176.
92. Mody, I., De Koninck, Y., Otis, T.S. and Soltesz, I. (1994). Bridging the cleft at GABA synapses in the brain. Trends Neurosci. 17, 517-525.
93. Moller, N.P. Scholz-Ahrens, K.E., Roos. N. and Schrezenmeir, J. (2008). Bioactive peptides and proteins from foods: indication for health effects. Eur. J. Nun: 47, 171-182.
94. Mora-Gutierrez, A. Farrell, H.M., Attaie, R., McWhinncy, V.J. and Wang, C. (2007), Influence of bovine and caprine casein phosphopeptides differing in alphas 1-casein content in determining the absorption of calcium from bovine and caprine calcium-fortified milks in rats. J. Dairy Res. 74, 356-366.
95. Nagao, K. and Yanagita, T. (2005), Conjugated fatty acids in food and their health benefits. J. Biosci. Bioeng. 100, 152-157.
96. Nakamura, Y., Yamamoto. N., Sakai, K. and Takano. T. (1995), Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme. J. Dairy Sci. 78, 1253-1257.
97. Narva, M., Karkkainen, M., Poussa, T., Lamberg-Allardt, C. and Korpela, R. (2003), Caseinphosphopeptides in milk and fermented milk do not affect calcium metabolism acutely in postmenopausal women. J. Am. Coll. Nutr. 22, 88-93.
98. Nomura, M., Kimoto, H., Someya, Y., Furukawa, S. and Suzuki, I. (1998), Production of gamma-aminobutyric acid by cheese starters during cheese ripening. J. Dairy Sci. 81, 1486-1491.
99. Nomura, M., Kimoto, H., Someya, Y. and Suzuki, I. (1999a), Novel characteristic for distinguishing Lactococcus lactis subsp. lactis from subsp. cremoris. Int. J. Syst. Bacteriol. 49 Pt 1, 163-166.
100. Nomura, M., Nakajima, I., Fujita, Y., Kobayashi, M., Kimoto, H., Suzuki, I. and Aso, H. (1999b), Lactococcus lactis contains only one glutamate decarboxylase gene. Microbiology 145 Pt 6, 1375-1380.
101. O' Hara, A. and Shanahan, F. (2007), Mechanisms of action of probiotics in intestinal diseases. Scientific World J. 7, 31-46.
102. Ogawa, J., Kishino, S., Ando, A., Sugimoto, S., Minara, K. and Shimizu, S. (2005), Production of conjugated fatty acids by lactic acid bacteria. J. Biosc. Bioeng. 100, 355-364.
103. Ogawa, J., Matsumura, K., Kishino, S., Omura, Y. and Shimizu, S. (2001), Conjugated linoleic acid accumulation via 10-hydroxy-12-octadecaenoic acid during microaerobic transformation of linoleic acid by Lactobacillus acidophilus. Appl. Environ. Microbiol. 67, 1246-1252.
104. Oh, C.-H. and Oh, S.-H. (2004), Effects of germinated brown rice extracts with enhanced levels of GABA on cancer cell proliferation and apoptosis J. Medicin. Food 7, 19-23.
105. Oh, S.-H., Soh, J.R. and Cha, Y.S. (2003), Germinated brown rice extract shows a neutraceutical effect in the recovery of chronic alcohol-related symptoms. J. Med. Food 6, 115-121.
106. Olsen, R.W. (2002), GABA. In Neuropsychopharmacology: The Fifth Generation of Progress. (Eds KL Davis, D Charney and JT Coyle). American College of Neuropsychopharmacology, pp 159-168.
107. Ouwehand, A.C. (2007), Antiallergic effects of probiotics. J. Nutr. 137, 794S-797S.
108. Pariza, M.W., Park, Y. and Cook, M.E. (2001), The biologically active isomers of conjugatd linoleic acid. Prog. Lip. Res. 40, 283-298.
109. Park, K.B., Ji, G.-E., Park, M.-S. and Oh, S.-H. (2005), Expression of rice glutamate decarboxylase in Bifidobacterium longum enhances γ-aminobutyric acid production Biotechnol. Lett. 27, 1681-1684.
110. Park, K.B. and Oh, S.H. (2004), Cloning and expression of a full length glutamate decarboxylase gene from Lactobacillusplantarum. J. Food Sci. Nutr. 9, 324-329.
111. Park, K.B. and Oh, S.H. (2006), Enhancement of γ-aminobutyric acid production in Chungkukjang by applying a Bacillus subtilis strain expressing glutamate decarboxylase from Lactobacillus brevis. Biotechnol. Lett. 28 1459-1463.
112. Park, K.B. and Oh, S.H. (2007), Cloning, sequencing and expression of a novel glutamate decarboxylase gene from a newly isolated lactic acid bacterium, Lactobacillus brevis OPK-3 Bioresource Technol. 98, 312-319.
113. Parodi, P.W. (2007), A role for milk proteins and their peptides in cancer prevention. Curr. Pharm. Des. 13, 813-828.
114. Pihlanto, A. (2001), Bioactive peptides derived from bovine whey proteins: opioid and ace-inhibitory peptides. Trends Food Sci. Technol. 11, 347-356.
115. Prioult, G., Pecquet, S. and Fliss, I. (2004), Stimulation of interleukin-10 production by acidic beta-lactoglobulin-derived peptides hydrolyzed with Lactobacillus paracasei NCC2461 peptidases. Clin. Diagn. Lab. Immun. 11, 266-271.
116. Racagni, G., Apud, J.A., Cocchi, D., Locatelli, V. and Muller, E.E. (1982), GABAergic control of anterior pituitary hormone secretion. Life Sci. 31 823-838.
117. Read, L.C, Lord, A.P., Brantl, V. and Koch, G. (1990), Absorption of beta-casomorphins from autoperfused lamb and piglet small intestine. Am. J. Physiol. 259, G443-G452.
118. Rizzello, C.G., Losito, I., Gobbetti, M., Carbonara, T., De Bari, M.D. and Zambonin, P.G. (2005), Antibacterial activities of peptides from the water-soluble extracts of Italian cheese varieties. J. Dairy Sci. 88, 2348-2360.
119. Roberts, E. and Frankel, S. (1950), Gamma-aminobutyric acid in brain: its formation from glutamic acid. J. Biol. Chem. 187, 55-63.
120. Rokka, T., Swyvaoja, E.L., Tuominen, J. and Korhonen, H. (1997), Release of bioactive peptides by enzymatic proteolysis of Lactobacillus GG fermented UHT milk Milchwissenschaft 52, 675-677.
121. Roudot-Algaron, F., Le Bars, D., Kerhoas, L., Einhorn, J. and Gripon, J.C. (1994), Phosphopeptides from Comte cheese. Nature and origin. J. Food Sci. 59, 544-547.
122. Rutherfurd, K.J. and Gill, H.S. (2000), Peptides affecting coagulation. Br. J. Nutr. 84 Suppl 1, S99-S102.
123. Sabikhi, L. and Mathur, B.N. (2001), Qualitative and quantitative analysis of β-casomorphins in Edam cheese. Milchwissenschaft 56, 198-202.
124. Saito, T. (2008), Antihypertensive peptides derived from bovine casein and whey proteins. Adv. Exp. Med. Biol. 606, 295-317.
125. Sanders, J.W., Leenhouts, K., Burghoorn, J., Brands, J.R., Venema, G. and Kok, J. (1998), A chloride-inducible acid resistance mechanism in Lactococcus lactis and its regulation. Mol. Microbiol. 27, 299-310.
126. Sanders, M.E. (1998), Overview of functional foods: emphasis on probiotic bacteria. Int. Dairy J. 8, 341-347.
127. Saxelin, M. (2008), Probiotic formulations and applications, the current probiotics market, and changes in the marketplace: a European perspective. Clin. Infect. Dis. 46 Suppl 2, S76-S9; discussion S144-S151.
128. Scholz-Ahrens, K.E. and Schrezenmeir, J. (2000), Effects of bioactive substances in milk on mineral and trace element metabolism with special reference to casein phosphopeptides. Br. J. Nutr. 84 Suppl 1, S147-53.
129. Seppo, L., Jauhiainen, T., Poussa, T. and R., K. (2003), A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am. J. Clin. Nutr. 77, 326-330.
130. Sheil, B., Shanahan, F. and O'Mahony, L. (2007), Probiotic effects on inflammatory bowel disease. J. Nutr. 137, 819S-824S.
131. Side, C. (2006), Overview on marketing functional foods in Europe. In 'Functional Food Network general meeting'.
132. Sieber, R., Collomb, M., Aeschlimann, A., Jelen, P. and Eyer, H. (2004), Impact of microbial cultures on conjugated linoleic acid in dairy products - a review. Int. Dairy J. 14, 1-15.
133. Silveira, M.B., Carraro, R., Monereo, S. and Tebar, J. (2007), Conjugated linoleic acid (CLA) and obesity. Public Health Nutr. 10, 1181-1186.
134. Singh, T.K., Fox, P.F. and Healy, A. (1997), Isolation and identification of further peptides in the diafiltration retentate of the water-soluble fraction of Cheddar cheese. J. Dairy Res. 64, 433-443.
135. Siragusa, S., De Angelis, M., Di Cagno, R., Rizzello, C.G., Coda, R. and Gobbetti, M. (2007), Synthesis of gamma-aminobutyric acid by lactic acid bacteria isolated from a variety of Italian cheeses. Appl. Environ. Microbiol. 73, 7283-7290.
136. Siro, I., Kapolna, E., Kapolna, B. and Lugasi, A. (2008), Functional food. Product development, marketing and consumer acceptance-A review. Appetite 51, 456-467.
137. Stanton, C., Murphy, J., McGrath, E. and Devery, R. (2003), Aninal feeding strategies for conjugated linoleic acid enrichment of milk. In Advances in Conjugated Linoleic Acid Research. (Eds JL Sebedio, WW Christie and RO Adlof). AOCS Press: Champaign, IL pp 123-145.
138. Stanton, C., Ross, R.P., Fitzgerald, G.F. and Van Sindern, D. (2005), Fermented functional foods based on probiotics and their biogenic metabolites. Curr. Opin. Biotechnol. 16, 198-203.
139. Stanton, H.C. (1963), Mode of action of gamma amino butyric acid on the cardiovascular system. Arch. Int. Pharmacodyn. 143 195-204.
140. Sutas, Y., Hurme, M. and Isolauri, E. (1996), Down-regulation of anti-CD3 antibody-induced IL-4 production by bovine caseins hydrolysed with Lactobacillus GG-derived enzymes. Scand. J. Immunol. 43, 687-689.
141. Teschemacher, H., Koch, G. and Brantl, V. (1997), Milk protein-derived opioid receptor ligands. Biopolymers 43, 99-117.
142. Teucher, B., Majsak-Newman, G., Dainty, J.R., McDonagh, D., FitzGerald, R.J. and Fairweather-Tait, S.J. (2006), Calcium absorption is not increased by caseinophosphopeptides. Am. J. Clin. Nutr. 84, 162-166.
143. Tsuchita, H., Suzuki, T. and Kuwata, T. (2001), The effect of casein phosphopeptides on calcium absorption from calcium-fortified milk in growing rats. Br. J. Nutr. 85, 5-10.
144. Ueno, H. (2000), Enzymatic and structural aspects on glutamate decarboxylase. J. Mol. Catal. 10, 67-79.
145. Ueno, Y., Hayakawa, K., Takahashi, S. and Oda, K. (1997), Purification and characterization of glutamate decarboxylase from Lactobacillus brevis IFO 12005. Biosci. Biotechnol. Biochem. 61, 1168-1171.
146. Valeille, K., Ferezou, J., Parquet, M., Amsler, G., Gripois, D., Quignard-Boulange, A. and Martin, J.C. (2006), The natural concentration of the conjugated linoleic acid, cis-9,trans-11, in milk fat has antiatherogenic effects in hyperlipidemic hamsters. J. Nutr. 136, 1305-1310.
147. van Minnen, L.P., Timmerman, H.M., Lutgendorff, F., Verheem, A., Harmsen, W., Konstantinov, S.R., Smidt, H., Visser, M.R., Rijkers, G.T., Gooszen, H.G., et al. (2007), Modification of intestinal flora with multispecies probiotics reduces bacterial translocation and improves clinical course in a rat model of acute pancreatitis. Surgery 141, 470-480.
148. Van Nieuwenhove, C.P., Oliszewski, R., Gonzalez, S.N. and Perez Chaia, A.B. (2007), Conjugated linoleic acid conversion by dairy bacteria cultured in MRS broth and buffalo milk. Lett. Appl. Microbiol. 44, 467-474.
149. Vinderola, G., Matar, C. and Perdigon, G. (2007), Milk fermentation products of L. helveticus R389 activate calcineurin as a signal to promote gut mucosal immunity. BMC Immunol. 8, 19-29.
150. Volpi, R., Chiodera, P., Caffarra, P., Scaglioni, A., Saccani, A. and Coiro, V. (1997), Different control mechanisms of growth hormone (GH) secretion between gamma-amino- and gamma-hydroxy-butyric acid: neuroendocrine evidence in Parkinson's disease. Psychoneuroendocrinology 22, 531-538.
151. Watras, A.C., Buchholz, A.C., Close, R.N., Zhang, Z. and Schoeller, D.A. (2007), The role of conjugated linoleic acid in reducing body fat and preventing holiday weight gain. Int. J Obes. (Lond) 31, 48M87.
152. Xu, S., Boylston, T.D. and Glatz, B.A. (2005), Conjugated linoleic acid content and organoleptic attributes of fermented milk products produced with probiotic bacteria. J. Agric. Food Chem. 53, 9064-9072.
153. Yamamoto, N., Akino, A. and Takano, T. (1994), Antihypertensive effects of different kinds of fermented milk in spontaneously hypertensive rats. Biosci. Biotechnol. Biochem. 58, 776-778.
154. Yamamoto, N., Maeno, M. and Takano, T. (1999), Purification and characterization of an antihypertensive peptide from a yogurt-like product fermented by Lactobacillus helveticus CPN4. J Dairy Sci. 82, 1388-1393.